Kura Oncology Inc (KURA)
10.06
-5.85
(-36.77%)
USD |
NASDAQ |
Nov 21, 16:00
10.25
+0.19
(+1.89%)
Pre-Market: 08:39
Kura Oncology Shareholders Equity (Quarterly): 423.77M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 423.77M |
| June 30, 2024 | 466.07M |
| March 31, 2024 | 505.08M |
| December 31, 2023 | 397.27M |
| September 30, 2023 | 429.94M |
| June 30, 2023 | 459.68M |
| March 31, 2023 | 395.18M |
| December 31, 2022 | 420.28M |
| September 30, 2022 | 419.62M |
| June 30, 2022 | 449.49M |
| March 31, 2022 | 476.25M |
| December 31, 2021 | 506.61M |
| September 30, 2021 | 533.76M |
| June 30, 2021 | 558.55M |
| March 31, 2021 | 585.99M |
| December 31, 2020 | 610.90M |
| September 30, 2020 | 306.50M |
| June 30, 2020 | 322.37M |
| March 31, 2020 | 203.20M |
| Date | Value |
|---|---|
| December 31, 2019 | 218.78M |
| September 30, 2019 | 233.58M |
| June 30, 2019 | 246.58M |
| March 31, 2019 | 149.56M |
| December 31, 2018 | 160.98M |
| September 30, 2018 | 174.61M |
| June 30, 2018 | 112.40M |
| March 31, 2018 | 124.80M |
| December 31, 2017 | 79.86M |
| September 30, 2017 | 89.20M |
| June 30, 2017 | 43.64M |
| March 31, 2017 | 50.24M |
| December 31, 2016 | 56.88M |
| September 30, 2016 | 63.67M |
| June 30, 2016 | 70.04M |
| March 31, 2016 | 76.07M |
| December 31, 2015 | 82.10M |
| September 30, 2015 | 37.78M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
203.20M
Minimum
Mar 2020
610.90M
Maximum
Dec 2020
434.46M
Average
439.71M
Median
Shareholders Equity (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 2.912M |
| Perspective Therapeutics Inc | 328.47M |
| Protalix BioTherapeutics Inc | 32.44M |
| Electromed Inc | 41.49M |
| Armata Pharmaceuticals Inc | -50.97M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 478.84M |
| Total Liabilities (Quarterly) | 55.07M |